Gufic Biosciences Ltd. company was founded on July 23, 1984 and is headquartered in Mumbai, India is engaged in the manufacture of pharmaceuticals, medicinal chemicals and botanical products. It operates through the following geographical segments: India, Africa, Asia, Europe, North America, Australia and South America. The Negative aspects of the company are...
#GUFICBIO NSE: GUFICBIO CMP: 227 TP: 270 SL: 205 TF: <6m RR > ~2 times Return > 18% GUFICBIO THYROCARE CNXPHARMA LUPIN SUNPHARMA SPARC DIVISLAB DRREDDY AUROPHARMA BALPHARMA GLENMARK SANOFI PFIZER BPLPHARMA MARKSANS BIOCON GRANULES IPCALAB LAURUSLABS NATCOPHARM GLAND ALKEM ZYDUSLIFE APOLLOHOSP FORTIS AARTIDRUGS ZYDUSWELL MAXHEALTH BAJAJHCARE Factors: BULLISH...
#VIMTALABS NSE: VIMTALABS CMP: 461 TP: 560 SL: 410 TF: <6m RR > 2 times Return > 22% THYROCARE CNXPHARMA LUPIN NSE:CIPLA SUNPHARMA SPARC DIVISLAB DRREDDY AUROPHARMA BALPHARMA GLENMARK SANOFI PFIZER BPLPHARMA MARKSANS BIOCON GRANULES IPCALAB LAURUSLABS NATCOPHARM GLAND ALKEM ZYDUSLIFE Factors: BULLISH WEDGE BREAKOUT Trend Following Rising Volume with rising...
Gufic Biosciences good around 195 for 215+ with Sl below 172 in mid to longterm
After 2 months consolidation breakout at top.